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INTRODUCTION
Obstructive sleep apnea syndrome (OSAS) is a condition
of sleep-disordered breathing, which is characterized by the
repetitive complete or partial collapses of the pharyngeal
airway during sleep. It has been known to frequently involve
middle-aged people and to be found in 2% of women and
4% of men (1). Patients with OSAS usually present excessive
daytime sleepiness, unrefreshing sleep, fatigue, and even depres-
sion, and these symptoms may lead them to serious work or
car accidents (2, 3). It has been reported that OSAS has numer-
ous comorbidities, such as obesity, diabetes mellitus, coronary
heart disease, stroke, congestive heart failure, cardiac arrhyth-
mia, and gastroesophageal reflux (4-7). In addition, it is also
an independent risk factor for hypertension (6, 8) and has a
close relationship with atherosclerotic cardiovascular disease
(7). Although the exact pathophysiological mechanisms are
not yet fully understood, repetitive reduction of blood oxy-
gen saturation, increased efforts to breathe, increased sympa-
thetic tone and subsequent rennin-angiotension-aldosterone
system are considered to be involved in the development of
cardiovascular diseases (7). Therefore, the assessment of car-
diac functions in OSAS patients is an essential step in clini-
cal settings.
Heart rate variability (HRV) analysis has been widely used
to non-invasively evaluate cardiac autonomic functions. Inves-
tigators have demonstrated that abnormal HRV is associated
with increased mortality or adverse cardiac events and that the
analysis of HRV can be a way of predicting sudden arrhyth-
mic death, myocardial infarction, angina pectoris, stroke mor-
tality, and even rapid progression of atherosclerosis in animals
(9-12). Changes of HRV parameters were also reported in OSAS
patients (13-15), and HRV analysis has been proposed as a
screening tool for OSAS (16). However, there are numerous
indices or variables in time or frequency domain analysis of
HRV, and researchers have reported slightly different findings
226
Doo-Heum Park, Chul-Jin Shin*,
Seok-Chan Hong
� , Jaehak Yu,
Seung-Ho Ryu, Eui-Joong Kim
� ,
Hong-Beom Shin
� , and Byoung-Hak Shin
Department of Psychiatry, Konkuk University School of
Medicine, Seoul; Department of Neuropsychiatry*,
Chungbuk National University School of Medicine,
Cheongju; Department of Otorhinolaryngology
� ,
Konkuk University School of Medicine, Seoul; 
Department of Psychiatry
� , Eulji University School of
Medicine, Seoul, Korea
Address for correspondence
Chul-Jin Shin, M.D.
Department of Neuropsychiatry, Chungbuk National
University School of Medicine, 410 Gaesin-dong,
Heungdeok-gu, Cheongju 361-711, Korea
Tel : +82.43-269-6235, Fax : +82.43-267-7951
E-mail : cjshin@chungbuk.ac.kr
*This paper was supported by Konkuk University in
2006.
J Korean Med Sci 2008; 23: 226-31
ISSN 1011-8934
DOI: 10.3346/jkms.2008.23.2.226
Copyright � The Korean Academy
of Medical Sciences
Correlation between the Severity of Obstructive Sleep Apnea and
Heart Rate Variability Indices
The risk of cardiovascular disease is known to be increased in obstructive sleep
apnea syndrome (OSAS). Its mechanism can be explained by the observation
that the sympathetic tone increases due to repetitive apneas accompanied by
hypoxias and arousals during sleep. Heart rate variability (HRV) representing car-
diac autonomic function is mediated by respiratory sinus arrhythmia, baroreflex-
related fluctuation, and thermoregulation-related fluctuation. We evaluated the heart
rate variability of OSAS patients during night to assess their relationship with the
severity of the symptoms. We studied overnight polysomnographies of 59 male
untreated OSAS patients with moderate to severe symptoms (mean age 45.4± ±
11.7 yr, apnea-hypopnea index [AHI]=43.2± ±23.4 events per hour, and AHI >15).
Moderate (mean age 47.1± ±9.4 yr, AHI=15-30, n=22) and severe (mean age 44.5
± ±12.9 yr, AHI >30, n=37) OSAS patients were compared for the indices derived
from time and frequency domain analysis of HRV, AHI, oxygen desaturation event
index (ODI), arousal index (ArI), and sleep parameters. As a result, the severe
OSAS group showed higher mean powers of total frequency (TF) (p=0.012), very
low frequency (VLF) (p= 0.038), and low frequency (LF) (p=0.002) than the mod-
erate OSAS group. The LF/HF ratio (p=0.005) was higher in the severe group com-
pared to that of the moderate group. On the time domain analysis, the HRV trian-
gular index (p=0.026) of severe OSAS group was significantly higher. AHI was cor-
related best with the LF/HF ratio (rp=0.610, p<0.001) of all the HRV indices. Accord-
ing to the results, the frequency domain indices tended to reveal the difference
between the groups better than time domain indices. Especially the LF/HF ratio
was thought to be the most useful parameter to estimate the degree of AHI in OSAS
patients.
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in their studies. If there is a good index which correlates well
with the severity of OSAS symptoms and also reflects increased
cardiac risk, it helps us better understand the pathophysiol-
ogy of increased cardiovascular morbidity in OSAS, and can
be a useful tool for clinicians. We examined the nocturnal
HRV of OSAS patients to find what parameter in time or fre-
quency domain analysis is the best to reflect the severity of
symptoms.
MATERIALS AND METHODS
Subjects
Fifty-nine untreated male OSAS patients were recruited
from two university hospitals in Seoul, and their mean±SD
age was 45.4±11.7 yr. All subjects met the following inclu-
sion criteria: 1) male, 2) less than 61 yr old, 3) normal elec-
trocardiogram at wakefulness, and 4) apnea-hypopnea index
(AHI) greater than 15. The patients who were on the antihy-
pertensive treatment or had a diagnosis of hypertension were
excluded. Other exclusion criteria were previous or current
cardiovascular diseases, pulmonary disorders, diabetes mellitus,
substance abuse, history of taking alcohol or other drugs with-
in 7 days before polysomnographic study, diagnosis of period-
ic limb movements during sleep (PLMS), disorders of autonom-
ic nervous system or endocrine system that can change blood
pressure, and history of operations or CPAP treatment for
OSAS. Informed consent was obtained prior to the study. The
protocol was approved by the institutional review board.
The subjects were categorized into two groups, moderate
OSAS group (n=22) and severe OSAS group (n=37). The for-
mer was defined as the subjects with the AHI greater than
15 but less than 30, and the later with the AHI equal to or
greater than 30.
Polysomnography
Polysomnographic recordings were done with Embla N7000
system (Medcare-Embla
�, Reykjavik, Iceland) using Somno-
logica version 3.3.1 software (Medcare-Embla
�, Reykjavik,
Iceland) during the time when the subjects were in bed from
light-off to light-on. Electroencephalography was monitored
using C3/A2 and C4/A1 leads pairs, and O1/A2 and O2/A1
leads were also used to easily detect alpha waves that are use-
ful to see onset of sleep and arousal. Two pairs of electro-ocu-
lographic leads were used. Electromyographic leads were
put on the submentalis and the tibialis anterior muscles.
Airflow was continuously measured by a thermistor and a
nasal pressure cannula. The respiratory movements were
monitored using the respiratory inductive plethysmograph-
ic belts around chest and abdomen. Oxygen saturation was
measured by a pulse oximeter sensor which was put on the
left second finger.
The oxygen desaturation event index (ODI) was defined as
the number of events per hour in which oxygen saturation de-
creases by 4% or more. Hypopnea was defined as a reduction
of airflow by 50-80% for at least 10 sec associated with either
oxygen desaturation of at least 4% or arousals. Apnea was de-
fined as an air flow reduction 80% or more for at least 10 sec
(17). AHI was calculated by dividing the total number of
apneas and hypopneas by the number of hours of sleep. The
evaluation of sleep stages was based on Rechtschaffen and
Kales’ study, and episodes of arousals were assessed accord-
ing to the guidelines in the previous studies (18).
Data acquisition and analysis
Electrocardiographic signals acquired by the polysomno-
graphic machine were digitalized with the sampling rate of
250 Hz. Artifacts were eliminated and the analysis was done
only for normal beats. Time domain variables were mean
RR, SDNN, SDNN index, RMSSD, NN50 count, NN50
of total HR (%), SDANN, and HRV triangular index. SDNN
is the standard deviation of all RR intervals. RMSSD is the
square root of the mean of the sum of the squares of differ-
ences between adjacent RR intervals. SDANN is the stan-
dard deviation of the averages of RR intervals in all 5-min
segments. The SDNN index is the mean of the standard
deviation of all RR intervals for all 5-min segments. NN50
count means the number of pairs of adjacent RR intervals
differing by more than 50 ms in the entire analysis interval.
NN50 of total HR (%) is the NN50 count divided by the
total number of all RR intervals. The HRV triangular index
means the total number of RR intervals divided by maxi-
mum height of the histogram excluding boundaries. In fre-
quency domain analysis, the power was calculated for very
low frequency (VLF, 0.0033-0.04 Hz), low frequency (LF,
0.04-0.15 Hz), and high frequency bands (HF, 0.15-0.40
Hz). The LF/HF ratio was also included in the statistics.
Comparisons between the two groups, moderate and severe
OSAS groups, were made for demographic data, sleep param-
eters and events, and HRV indices by independent t-test. Sleep
events in the analysis were AHI, ODI, average O2 saturation,
arousal index, limb movement and snoring time. Partial cor-
relations controlling age and Body Mass Index (BMI) were
evaluated for AHI versus HRV indices. The significance level
was defined as p<0.05.
RESULTS
The differences of mean age (47.1±9.4 vs. 44.5±12.9 yr)
and BMI (26.1±3.9 vs. 27.8±3.8 kg/m2) were not signifi-
cant between the moderate and the severe OSAS groups.
The sleep profiles and sleep event data of the subjects were
shown in Table 1. The proportion of stage 1 sleep was greater
in the severe OSAS group than in the moderate OSAS group228 D.-H. Park, C.-J. Shin, S.-C. Hong, et al.
(p=0.003). Other variables of the sleep profile revealed no
difference. The mean AHI for the moderate OSAS group
was 21.2±4.7, and 56.4±19.8 for the severe OSAS group.
There was no a significant difference in snoring time between
the two groups. The severe OSAS group showed a significantly
higher ODI (p<0.001), lower average SpO2 (p<0.001), and
higher total number of episodic limb movements (p=0.010)
than the moderate OSAS group. The severe OSAS group
showed higher respiratory (p<0.001) and total arousal indices
(p<0.001) with no difference of spontaneous arousal index
as compared to the moderate OSAS group.
Time domain variables did not demonstrate any differences
between the groups except for HRV triangular index (Table
2). The HRV triangular index of the moderate OSAS group
OSAS, obstructive sleep apnea syndrome; TIB, time in bed; SPT, sleep period time; TST, total sleep time; SL, sleep latency; SE, sleep efficiency; S1,
stage 1 sleep; S2, stage 2 sleep; S3, stage 3 sleep; S4, stage 4 sleep; REM, REM sleep stage; Wake, wakeful state; AHI, apnea-hypopnea index; ODI,
oxygen desaturation event index; LM, limb movements; ArI, arousal index.
Variable t p
Moderate OSAS (n=22) Severe OSAS (n=37)
Mean SD Mean SD
TIB (min) 456.75  69.68 460.67 66.16 -0.216 0.830
SPT (min) 441.39 68.98 450.02 66.81 -0.474 0.637
TST (min) 394.35 95.96 403.15 82.53 -0.372 0.711
SL (min) 15.35 35.49 10.64 12.10 0.742 0.461
SE (%) 86.96 15.98 88.32 12.50 -0.363 0.718
Awakenings 7.18 6.01 7.57 6.64 -0.223 0.824
S1 (%) 17.66 6.43 28.25 15.23 -3.090 0.003
S2 (%) 45.96 13.08 40.51 13.92 1.485 0.143
S3 (%) 4.74 3.52 5.26 6.76 -0.297 0.768
S4 (%) 8.18 6.18 5.31 8.02 0.879  0.389
REM (%) 18.17  7.10 14.71 6.99 1.817 0.075
Wake (%) 11.58 12.87 10.50 12.41 0.319 0.751
AHI 21.2 4.7 56.4 19.8 -8.20 <0.001
Snoring (min) 167.49  109.20 154.02 116.43 0.422 0.675
Snoring (%) 40.60 24.48 34.34 25.06 0.907 0.368
ODI 14.66 6.32  48.06  22.51 -6.781 <0.001
Average SpO2 95.05 1.23 92.40 3.13 3.794 <0.001
LM 85.81 73.65 157.15 108.11 -2.662 0.010
ArI (respiratory) 10.73 4.89  35.92 20.75 -5.584  <0.001
ArI (spontaneous) 6.93 3.66 6.88 9.58 0.022  0.983
ArI (total) 18.80 6.16 43.26 17.67  -6.252  <0.001
Table 1. Sleep profiles and events of the subjects with obstructive sleep apnea syndrome
OSAS, obstructive sleep apnea syndrome; SDNN, standard deviation of NN interval; RMSSD, square root of the mean squared differences of succes-
sive NN intervals; NN50, the number of interval differences of successive NN intervals greater than 50 ms; SDANN, standard deviation of average NN
interval; HRV TI, heart rate variability triangular index; VLF, very low frequency; LF, low frequency; HF, high frequency.
Variable t p
Moderate OSAS (n=22) Severe OSAS (n=37)
Mean SD Mean SD
RR Interval (ms) 971.23 154.37 903.19  117.90 1.907  0.062
SDNN (ms) 94.14 26.52 109.19 63.98 -1.048 0.299
SDNN index (ms) 71.86 24.58 90.14 66.23 -1.241 0.220
RMSSD (ms) 57.32 31.18 64.97 85.40 -0.404 0.688
NN50 count 4796.14 4464.33 5132.14 4329.50 -0.285 0.777
NN50 of total HR (%) 18.53 17.52 18.01 15.62 0.118 0.906
SDANN (ms) 57.36 28.29 53.86 23.78 0.509 0.613
HRV TI 17.36 4.72 21.60 7.84 -2.292 0.026
Total power (ms
2) 13,682 4,643 19,270 9,429 -2.592 0.012
VLF power (ms
2) 8,523 3,615 12,038 7,216 -2.126 0.038
LF power (ms
2) 3,135 1,145 5,292 3,059 -3.169 0.002
HF power (ms
2) 1,885 1,108 1,738 1,523 0.396 0.694
LF/HF ratio 2.03 1.08 4.38  3.67 -2.922 0.005
Table 2. Time and frequency domain variables of the heart rate variability of the subjects with obstructive sleep apnea syndromeSeverity of Obstructive Sleep Apnea and Heart Rate Variability 229
was significantly lower than the severe OSAS group (17.4
±4.7 and 21.6±7.8 respectively, p=0.026). In frequency
domain analysis, total power (p=0.012), VLF power (p=0.038),
LF power (p=0.002), and LF/HF ratio (p=0.005) were greater
in the severe OSAS group than in the moderate OSAS group
with no difference of HF power (Table 2).
In the correlation analysis between AHI and HRV indices
controlling age and BMI (Table 3), AHI showed positive cor-
relations with total power (rp=0.313, p=0.018), VLF power
(rp=0.286, p=0.031), LF power (rp=0.395, p=0.002) and LF/
HF ratio (rp=0.610, p<0.0001), but a negative correlation with
RR interval (rp=-0.370, p=0.005). The most significantly pos-
itive relationship with AHI was found in the LF/HF ratio
(Fig. 1).
DISCUSSION
It is quite proper that the severe OSAS group had greater
oxygen desaturation, arousal indices and lower SpO2 than the
moderate symptom group because the mean AHI was com-
pletely different from each other according to the definition
of the groups. The increased ventilatory effort that results
from obstructed breathings in apneic or hypopneic episodes
causes frequent arousals (7). More frequent arousals in the pa-
tients with severe symptoms might prevent them from falling
into deep sleep, and it can also explain increased limb move-
ments in this group.
In time domain analysis, most parameters failed to make
significance in the statistical comparison between the groups.
The only time domain variable demonstrating the difference
was the HRV triangular index. The HRV triangular index
can be calculated by the integral of the density distribution
divided by the maximum of the density distribution of nor-
mal-to- normal (NN) interval. The HRV triangular index
tends to correlate with total power in frequency domain anal-
ysis. It also reflects the overall amount of variability and has
known to be affected by both sympathetic and parasympa-
thetic activity but more influenced by lower bands than high-
er bands (19). The significant difference of the HRV triangu-
lar index in this study can be interpreted to have been affected
by the influence of lower frequency component, because HF
did not show the difference. Although the LF component has
been regarded as a parameter reflecting sympathetic activi-
ty, it is far from conclusive whether this result about the HRV
triangular index means increased sympathetic tone, because
not only LF but also VLF power contributed to the signifi-
cance of total power. In spite of a few previous studies that
reported increases of VLF component in OSAS patients (20,
21) and synchronized VLF behavior with hypoxemia (22),
the exact physiological meaning of VLF still remains in debate.
One of the possible explanations for the reason why most
time domain variables were not better than frequency domain
variables in differentiating the two groups in this study is
that frequency domain techniques may be better than time
domain analysis in the precise evaluation of changes of sym-
pathovagal balance (19).
In the frequency study, all variables but HF power were
found to be significantly greater in the patients with severe
symptoms. The difference between the groups depended on
the power of very low and low frequency bands. It can account
VLF, very low frequency; LF, low frequency; HF, high frequency; SDNN,
standard deviation of NN interval; RMSSD, square root of the mean sq-
uared differences of successive NN intervals; NN50, the number of inter-
val differences of successive NN intervals greater than 50 ms; SDANN,
standard deviation of average NN interval.
Variable
AHI
rp p
Total power (ms
2) 0.313 0.018
VLF power (ms
2) 0.286 0.031
LF power (ms
2) 0.395 0.002
HF power (ms
2) -0.196 0.143
LF/HF ratio 0.610 <0.0001
RR Interval (ms) -0.370 0.005
SDNN (ms) 0.035 0.799
SDNN index (ms) 0.079 0.561
RMSSD (ms) -0.030 0.825
NN50 count -0.021 0.880
NN50 of total HR (%) -0.093 0.491
SDANN (ms) -0.159 0.237
HRV triangular index 0.153 0.254 
Table 3. Partial correlation of apnea-hypopnea index (AHI) and
heart rate variability (HRV) indices controlling age and body mass
index of the subjects with obstructive sleep apnea syndrome
Fig. 1. The correlation between AHI and LF/HF ratio controlling
age and body mass index is shown by positive relationship (rp=
0.610, p<0.0001) in the subjects with obstructive sleep apnea
syndrome. AHI, apnea-hypopnea index; LF, low frequency; HF,
high frequency.
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for the greater total power in the patients with severe symp-
toms because HF power revealed no difference. Parasympa-
thetic control for heart rate has a very short latency enabling
a beat-to-beat basis change, but synaptic norepinephrine medi-
ating sympathetic influence is metabolized relatively slowly
(19). In different way from respiratory sinus arrhythmia that
occurs at a high frequency, baroreceptor-mediated heart rate
variation has a lower frequency variation about 0.10 Hz and
can be significantly diminished by sympathetic blockade (19,
23). The HF component has been known to be associated
with parasympathetic activity, and LF power was proposed
as an index that is affected by the activity of sympathetic
nervous system. However, there has been no complete agree-
ment about the meaning of the LF component. Mostly sym-
pathetic activity or both sympathetic and parasympathetic
activities are thought to contribute to the LF component of
HRV. The LF finding without a HF change in this study can
be thought to implicate increased sympathetic tone in the
severe patients compared with the moderate symptoms group.
The LF/HF ratio was found to have a better statistical sig-
nificance for differentiating the two study groups and to have
better correlation with OSAS severity than other variables in
frequency analysis. One possible reason for this is that the
LF/HF ratio with less contribution of parasympathetic activity
would reflect sympathetic activity better than the LF compo-
nent itself. Another possible reason that can explain why the
LF/HF ratio demonstrated a better significance than LF power
is that the LF/HF ratio is a normalized parameter without an
effect of total power that can be variable with experimental
conditions.
There were some previous studies in which investigators
tried to find a relationship between OSAS severity and HRV
parameters. Narkiewicz and colleagues found a increased
LF/HF ratio, HF power, and normalized LF power in patients
with moderate-to-severe OSAS patients compared to nor-
mal controls, and a greater LF/HF ratio compared to mild
OSAS patients (24). Gula and colleagues reported that the
LF/HF ratio was higher among patients with moderate OSA
compared to normals and interestingly those with severe
OSA (25). Aydin and colleagues reported that total power,
VLF, LF, and LF/HF ratio were higher in patients than those
in controls, and that LF and LF/HF ratio were increased in
severe OSAS group compared with mild OSAS group (21),
but Yang and colleagues study did not find any difference
of time or frequency variables between mild-to-moderate
and moderate-to-severe OSAS patients (26). Because their
methods were different in the criteria for patients classifica-
tion, length of time series, hours for getting signals, and
ways of analysis, direct comparisons of the results cannot be
justified. However, the increased LF power and LF/HF ratio
in OSAS patients are relatively consistent findings. The tem-
porary reduction of the oxyhemoglobin level in apnea or
hypopnea episodes is known to result in the activation of
sympathetic nervous system and subsequent stimulation of
the rennin-angiotension-aldosterone system. The relation-
ship of OSAS and systemic hypertension can be attributed
to these physiological mechanisms (27). Because LF power
and LF/HF ratio have been regarded as indices indicating
sympathetic tone or sympathovagal balance, it is plausible to
assume that the greater AHI, the greater LF or LF/HF ratio.
This study suggests that the LF/HF ratio can be an appro-
priate index estimating the severity of OSAS symptoms and
that it can be a good candidate for a screening tool with an
oximetry for apnea-hypopnea syndrome. Regardless of its
usefulness, there have been continuous efforts to find appro-
priate screening methods for OSAS (28-30). The reduction
of the arterial oxygen level is a direct consequence of apnea
and hypopnea, but a screening only with oximetry does not
have a good sensitivity (29). The LF/HF ratio may be useful
because this study showed that it has a linear correlation with
AHI.
Frequency analysis has been done usually for short-term
HRV data because there is a stationary problem in the long-
term data, and it often makes the meaning of the data obscure.
However, this result found that the LF/HF ratio still has a
meaningful relationship with the severity of the symptoms
in the long-term HRV. A limitation is that there was not a
normal control group in this study, but there seemed to be no
disagreement about the increased LF/HF ratio in the patients
through previous studies. Verification of its usability as a
screening method needs further studies.
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